TOP RANKED ROSEN LAW FIRM Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, IBM and IRNT Pharmaceutical Investing
AUPH SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Veklury® is First and Only Approved Treatment for Pediatric Patients Under 12 Years of Age with COVID-19 Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ERIC, AI and ABBV Pharmaceutical Investing
ABBV Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of June 6, 2022 Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
LAWSUITS FILED AGAINST MP, CRNC and AUPH - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS Pharmaceutical Investing
SHAREHOLDER ALERT: AI GRAB ABBV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Aptose to Report First Quarter 2022 Financial Results and Hold Conference Call on Monday, May 9, 2022 Market News
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022 Pharmaceutical Investing
Several New Studies Presented at ECCMIC 2022 Confirm Veklury® Activity in Treating COVID-19 Pharmaceutical Investing
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AUPH Pharmaceutical Investing
